Seminar held on DPP-4 inhibitors and COVID-19 related outcomes among patients with T2D | The Daily Star
12:00 AM, March 07, 2021 / LAST MODIFIED: 12:00 AM, March 07, 2021

Seminar held on DPP-4 inhibitors and COVID-19 related outcomes among patients with T2D

A scientific seminar on "DPP-4 inhibitors and COVID-19 related outcomes among patients with type 2 diabetes (T2D)" was organised by NIPRO JMI Pharma Ltd. at the capital recently, says a press release. Distinguished Professor AK Azad Khan, President of Bangladesh Diabetic Association, was the chief guest at the event.

The session speaker, renowned endocrinologist Dr Md Feroz Amin presented that the use of DPP-4 inhibitors in COVID-19 patients with diabetes might significantly lower the probability of all-cause mortality and severe manifestations of COVID-19.

For all latest news, follow The Daily Star's Google News channel.

 

Stay updated on the go with The Daily Star Android & iOS News App. Click here to download it for your device.

Grameenphone:
Type START <space> BR and send SMS it to 22222

Robi:
Type START <space> BR and send SMS it to 2222


Banglalink:
Type START <space> BR and send SMS it to 2225

Leave your comments

Top News

Top News

Top